Literature DB >> 16956921

Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

Laurent Peyrin-Biroulet1, Mathias Chamaillard, Florent Gonzalez, Elodie Beclin, Cecilia Decourcelle, Laurent Antunes, Jérôme Gay, Christel Neut, Jean-Frédéric Colombel, Pierre Desreumaux.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16956921      PMCID： PMC1856873          DOI： 10.1136/gut.2005.082925

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  68 in total

1.  Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli.

Authors:  Christos Tsatsanis; Vassiliki Zacharioudaki; Ariadne Androulidaki; Erini Dermitzaki; Ioannis Charalampopoulos; Vassilis Minas; Achille Gravanis; Andrew N Margioris
Journal:  Biochem Biophys Res Commun       Date:  2005-10-07       Impact factor: 3.575

2.  Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.

Authors:  Hye Soon Park; Jung Yul Park; Rina Yu
Journal:  Diabetes Res Clin Pract       Date:  2004-12-30       Impact factor: 5.602

3.  Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2.

Authors:  Martha Lappas; Michael Permezel; Gregory E Rice
Journal:  Endocrinology       Date:  2005-05-19       Impact factor: 4.736

Review 4.  Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come.

Authors:  Antje Koerner; Jürgen Kratzsch; Wieland Kiess
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-12       Impact factor: 4.690

5.  Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

Authors:  A Okuno; H Tamemoto; K Tobe; K Ueki; Y Mori; K Iwamoto; K Umesono; Y Akanuma; T Fujiwara; H Horikoshi; Y Yazaki; T Kadowaki
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

Review 6.  Review article: adipocytokines and insulin resistance.

Authors:  R Vettor; G Milan; M Rossato; G Federspil
Journal:  Aliment Pharmacol Ther       Date:  2005-11       Impact factor: 8.171

7.  Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells.

Authors:  Shinji Saijo; Kisaburo Nagata; Yasuko Nakano; Takashi Tobe; Yoshiro Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

8.  Variability of abdominal adipose tissue measurements using computed tomography in prepubertal girls.

Authors:  R Figueroa-Colon; M S Mayo; M S Treuth; R A Aldridge; G R Hunter; L Berland; M I Goran; R L Weinsier
Journal:  Int J Obes Relat Metab Disord       Date:  1998-10

9.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

10.  Disorders of fat distribution in HIV infection.

Authors:  A J Shaw; K A McLean; B A Evans
Journal:  Int J STD AIDS       Date:  1998-10       Impact factor: 1.359
View more
  62 in total

1.  The effect of body weight on the severity and clinical course of ulcerative colitis.

Authors:  Denia Stabroth-Akil; Ludger Leifeld; Roland Pfützer; Julia Morgenstern; Wolfgang Kruis
Journal:  Int J Colorectal Dis       Date:  2014-11-14       Impact factor: 2.571

Review 2.  Adipose tissue and inflammatory bowel disease pathogenesis.

Authors:  Christopher Fink; Iordanes Karagiannides; Kyriaki Bakirtzi; Charalabos Pothoulakis
Journal:  Inflamm Bowel Dis       Date:  2012-03-08       Impact factor: 5.325

Review 3.  Extraluminal factors contributing to inflammatory bowel disease.

Authors:  Arvind Batra; Thorsten Stroh; Britta Siegmund
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

4.  Is obesity a risk factor for Crohn's disease?

Authors:  Michael A Mendall; A Viran Gunasekera; B Joseph John; Devinder Kumar
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

5.  Inflammation: an equal-opportunity process.

Authors:  David B Sachar
Journal:  Dig Dis Sci       Date:  2011-03       Impact factor: 3.199

6.  Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease.

Authors:  Reena Khanna; Barrett G Levesque; William J Sandborn; Brian G Feagan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-08

7.  Toll-like receptor 4, F4/80 and pro-inflammatory cytokines in intestinal and mesenteric fat tissue of Crohn's disease.

Authors:  Raquel F Leal; Marciane Milanski; Maria de Lourdes S Ayrizono; Andressa Coope; Viviane S Rodrigues; Mariana Portovedo; Luiza M F Oliveira; João J Fagundes; Cláudio S R Coy; Lício A Velloso
Journal:  Int J Clin Exp Med       Date:  2013-01-26

Review 8.  Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease?

Authors:  Ellen S Pierce
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

9.  Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways.

Authors:  Kara Gross; Iordanes Karagiannides; Thomas Thomou; Hon Wai Koon; Collin Bowe; Ho Kim; Nino Giorgadze; Tamara Tchkonia; Tamara Pirtskhalava; James L Kirkland; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-12       Impact factor: 4.052

10.  Association of clinical and radiographic features with perinephric "sticky" fat.

Authors:  Jason R Bylund; Han Qiong; Paul L Crispen; Ramakrishna Venkatesh; Stephen E Strup
Journal:  J Endourol       Date:  2012-11-27       Impact factor: 2.942
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.